Ad is loading...
GOSS
Price
$0.74
Change
-$0.03 (-3.90%)
Updated
Nov 15 closing price
123 days until earnings call
LEGN
Price
$38.19
Change
-$1.70 (-4.26%)
Updated
Nov 15 closing price
115 days until earnings call
Ad is loading...

GOSS vs LEGN

Header iconGOSS vs LEGN Comparison
Open Charts GOSS vs LEGNBanner chart's image
Gossamer Bio
Price$0.74
Change-$0.03 (-3.90%)
Volume$620.91K
CapitalizationN/A
Legend Biotech
Price$38.19
Change-$1.70 (-4.26%)
Volume$2.3M
CapitalizationN/A
GOSS vs LEGN Comparison Chart
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LEGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GOSS vs. LEGN commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Sell and LEGN is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (GOSS: $0.74 vs. LEGN: $38.19)
Brand notoriety: GOSS and LEGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 71% vs. LEGN: 171%
Market capitalization -- GOSS: $167.71M vs. LEGN: $7.01B
GOSS [@Biotechnology] is valued at $167.71M. LEGN’s [@Biotechnology] market capitalization is $7.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileLEGN’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • LEGN’s FA Score: 0 green, 5 red.
According to our system of comparison, GOSS is a better buy in the long-term than LEGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 4 TA indicator(s) are bullish while LEGN’s TA Score has 4 bullish TA indicator(s).

  • GOSS’s TA Score: 4 bullish, 7 bearish.
  • LEGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LEGN is a better buy in the short-term than GOSS.

Price Growth

GOSS (@Biotechnology) experienced а -15.79% price change this week, while LEGN (@Biotechnology) price change was -4.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

GOSS is expected to report earnings on Mar 21, 2025.

LEGN is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LEGN($7.01B) has a higher market cap than GOSS($168M). GOSS YTD gains are higher at: -18.893 vs. LEGN (-36.530). GOSS has higher annual earnings (EBITDA): -59.72M vs. LEGN (-243M). LEGN has more cash in the bank: 1.29B vs. GOSS (354M). GOSS has less debt than LEGN: GOSS (199M) vs LEGN (339M). LEGN has higher revenues than GOSS: LEGN (456M) vs GOSS (95.8M).
GOSSLEGNGOSS / LEGN
Capitalization168M7.01B2%
EBITDA-59.72M-243M25%
Gain YTD-18.893-36.53052%
P/E RatioN/AN/A-
Revenue95.8M456M21%
Total Cash354M1.29B27%
Total Debt199M339M59%
TECHNICAL ANALYSIS
Technical Analysis
GOSSLEGN
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 24 days ago
83%
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
75%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
LEGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FTSM59.880.02
+0.03%
First Trust Enhanced Short Maturity ETF
PCRB48.450.01
+0.01%
Putnam ESG Core Bond ETF
MGOV20.02-0.01
-0.04%
First Trust Intermediate Gvt Opps ETF
JANW33.35-0.02
-0.07%
AllianzIM US Large Cap Buffer20 Jan ETF
BUYZ36.98-0.52
-1.38%
Franklin Disruptive Commerce ETF

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with MEIP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then MEIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-3.88%
MEIP - GOSS
46%
Loosely correlated
-2.99%
CGEM - GOSS
45%
Loosely correlated
-9.41%
SYRE - GOSS
41%
Loosely correlated
-6.62%
APVO - GOSS
41%
Loosely correlated
-12.45%
VIR - GOSS
41%
Loosely correlated
-7.29%
More

LEGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LEGN has been loosely correlated with AXON. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LEGN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEGN
1D Price
Change %
LEGN100%
-4.26%
AXON - LEGN
37%
Loosely correlated
-0.86%
BGNE - LEGN
34%
Loosely correlated
-2.10%
ALNY - LEGN
33%
Loosely correlated
-8.67%
GOSS - LEGN
33%
Poorly correlated
-3.88%
ORMP - LEGN
33%
Poorly correlated
-4.50%
More